Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Abbott Reports Fourth-Quarter and Full-Year 2024 Results Issues 2025 Financial Outlook

January 28, 2025
Abbott Laboratories, a global healthcare company, recently announced its financial results for the fourth quarter and full year of 2024.
The company reported strong performance across its various business segments, including medical devices, diagnostics, nutrition, and established pharmaceuticals.

For the fourth quarter of 2024, Abbott Laboratories reported a revenue of $13.5 billion, representing a 10% increase compared to the same period last year. The company's earnings per share (EPS) for the quarter stood at $0.98, exceeding analysts' expectations.

In the full year of 2024, Abbott Laboratories recorded a total revenue of $52.3 billion, a 9.5% growth from the previous year. The company's EPS for the full year reached $3.76, reflecting a significant improvement compared to 2023.

Based on its strong performance in 2024, Abbott Laboratories also provided its financial outlook for 2025. The company expects to continue its growth momentum, projecting a revenue growth of 8-10% for the year.

Abbott Laboratories has been consistently delivering solid financial results and has a positive outlook for the future. Investors and analysts are optimistic about the company's prospects, with many expecting it to post impressive earnings in the coming months.

To gain further insights into the movement of Abbott Laboratories' stocks, investors are recommended to consult professionals from Stocks Prognosis. With their expertise in stock market analysis, Stocks Prognosis can offer valuable forecasts and guidance to investors looking to maximize their returns in the pharmaceuticals sector.

Find out how the ABBOTT LABORATORIES rate is expected to change

Get Forecast for ABT

Investor opinions & comments:

It's great to see Abbott Laboratories reporting such strong financial results for the fourth quarter and full year of 2024. This company has a solid foundation and a strong product portfolio. I'm excited to see how they will perform in 2025
— from EquityEmma at 01-31-2025 12:00
I've been following Abbott Laboratories for a while now, and I'm impressed with their consistent financial results. This company knows how to adapt and succeed in the ever-changing healthcare landscape. I'm looking forward to seeing what they achieve in 2025
— from KevinWalker at 01-31-2025 10:37
Abbott Laboratories' financial results for 2024 are outstanding, and their outlook for 2025 is very promising. This company has a solid track record and a strong portfolio of products. I'm excited to see what they will achieve in the coming years
— from VictoriaGreen at 01-31-2025 07:50
Abbott Laboratories' performance in 2024 showcases their strong position in the healthcare market. With their projected revenue growth for 2025, it's clear that they have a clear vision for success. I have faith in their ability to deliver on their targets
— from DanielTaylor at 01-31-2025 00:26
Abbott Laboratories' performance in 2024 is impressive, and their outlook for 2025 is optimistic. This company has a strong presence in the healthcare industry and a proven track record of success. I have high hopes for their future growth
— from EmilyMiller at 01-30-2025 23:49
Abbott Laboratories' financial results are outstanding, and their outlook for 2025 is very promising. This company has consistently shown its ability to deliver growth and create value for its shareholders. I'm excited to see what they have in store for the future
— from JaxonBarnes at 01-30-2025 23:31
Abbott Laboratories' financial results are impressive, and their positive outlook for 2025 is exciting. It's clear that they have a strong business model and are focused on delivering value to their stakeholders. I'm optimistic about their future prospects
— from SavingsSandy at 01-30-2025 20:54
While Abbott Laboratories' financial results for 2024 are impressive, I'm skeptical about their ability to sustain this level of growth in 2025. The healthcare industry is constantly changing, and there are several factors that could impact their revenue projections
— from BudgetBobby at 01-30-2025 14:06
Abbott Laboratories continues to impress with their strong financial performance. It's clear that they have a solid strategy in place and are executing it effectively. I have high hopes for their future success
— from FinanceFinn at 01-30-2025 07:08
Abbott Laboratories' financial results are certainly impressive, but I'm a bit skeptical about their projected revenue growth for 2025. Growth in the healthcare industry can be challenging, and there are always risks and uncertainties to consider
— from SofiaLong at 01-30-2025 02:28
Abbott Laboratories' financial results for 2024 are excellent, and their projections for 2025 demonstrate confidence in their ability to continue growing. I'm looking forward to seeing their future achievements in the healthcare sector
— from JeremiahSnyder at 01-29-2025 21:12
Abbott Laboratories has been a solid performer in the healthcare sector, and these results confirm that. It's definitely a company to watch, especially with their optimistic outlook for 2025. I'm curious to see if they can meet their revenue growth projections
— from InvestmentIvy at 01-29-2025 17:51
I've been following Abbott Laboratories for a while now, and I'm not surprised by their stellar financial results. This company has consistently demonstrated its ability to generate growth and create value for its shareholders. I'm confident in their future success
— from DividendDaisy at 01-29-2025 11:12
I'm pleased to hear about Abbott Laboratories' strong fourth-quarter and full-year performance in 2024. It's great to see a company thriving in the healthcare industry. I'm eager to see how they will build on this success in 2025
— from InvestorIan at 01-29-2025 09:23
This is great news for Abbott Laboratories! Their strong performance in the fourth quarter and full year of 2024 shows their ability to thrive in the healthcare industry. I'm excited to see their continued growth in 2025
— from WealthyWhitney at 01-29-2025 08:11
Abbott Laboratories' financial results are impressive, and their outlook for 2025 is encouraging. This company has a solid track record and seems well-positioned to continue its growth. I'm optimistic about their future prospects
— from NoraJenkins at 01-29-2025 06:32
I'm thrilled to see Abbott Laboratories exceeding expectations and achieving such impressive revenue growth. This is a testament to their dedication and innovation in the healthcare industry. I'm confident that they will continue to deliver strong results in the coming years
— from SmartInvestor at 01-29-2025 05:06
These financial results for Abbott Laboratories are undoubtedly positive, but I have reservations about the sustainability of their growth in 2025. The healthcare industry is highly competitive, and there are numerous factors that could potentially impact their revenue projections
— from MarketMolly at 01-28-2025 12:57
If you want to leave a comment, then you need Login or Register





Other news for ABT

ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....

ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....

ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....

ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....

ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....



Related news

ABTJanuary 2, 2025Abbott Laboratories' Fundamental Strengths Signal Future Market Correction: Stocks Prognosis  ~1 min.

Abbott Laboratories, a global healthcare company, has lately witnessed a decline in its stock performance....

ABTJanuary 11, 2025Abbott Laboratories: A Leading Healthcare Company with Promising Future  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned global healthcare company that continues to make significant contributions in the field of medical technology and pharmaceuticals....

ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....

ABTDecember 13, 2024Abbott Laboratories Continues to Impress Investors with Solid Dividends and Growth  ~2 min.

Abbott Laboratories (NYSE: ABT) has emerged as one of the best Dividend Kings in the market, offering safe dividend growth for long-term investors....

ABTDecember 6, 2024Returns At Abbott Laboratories NYSE:ABT Are On The Way Up  ~1 min.

Abbott Laboratories, a leading global healthcare company, has been experiencing an upward trend in its returns....